Usefulness of the Cognitive Composition Test as an Early Discriminator of Mild Cognitive Impairment
Journal of Clinical Medicine · 02.02.2023 · 12 (3) · 1203
DOI: 10.3390/jcm12031203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.02.2023. Verfasst von Yoshiki Tamaru und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Rehabilitation, Shijonawate-Gakuen University, Hojo 5-11-10, Daito 574-0011, Osaka, Japan. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.
Abstract (Originalsprache)
Mild cognitive impairment (MCI) is the preliminary stage of dementia, which is a serious social problem worldwide. This study aimed to investigate whether the Cognitive Composition Test (CCT) is effective for the early diagnosis of MCI. A total of 104 older adults underwent the Montreal Cognitive Assessment (MoCA), the Mini-Mental State Examination (MMSE), the Trail Making Test Parts A (TMT-A) and B (TMT-B), and our newly prototyped cognitive composition test (CCT). We created three types of CCT (CCT-A, CCT-B, and CCT-C) with different degrees of difficulty. First, we examined the concurrent validity of CCT-A, CCT-B, and CCT-C with the MoCA, MMSE, TMT-A, and TMT-B. All participants were classified into the healthy control (HC) and MCI groups based on their scores in the Japanese versions of the MoCA and MMSE. The HC and MCI groups were compared using the TMT-A, TMT-B, CCT-A, CCT-B, and CCT-C. Finally, we examined the sensitivity for discrimination of CCT-C. CCT-C had a higher discrimination sensitivity than TMT-A, TMT-B, CCT-A, and CCT-B, with a cut-off value of 65.75 s, a sensitivity level of 0.844, and a specificity of 0.776. It may be a useful screening tool for the early diagnosis of the early-stages of dementia, such as MCI, in asymptomatic older adults.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Rehabilitation, Shijonawate-Gakuen University, Hojo 5-11-10, Daito 574-0011, Osaka, Japan.
- Department of Rehabilitation, Geriatric Health Service Facility Sungarden Fuchu, Sansocho, 2-1-15, Izumi 594-0021, Osaka, Japan.
ORCID-Profile: Yoshiki Tamaru, Akiyoshi Matsugi
Förderung
- Japan Society for the Promotion of Science
- JSPS KAKENHI
Zitieren
APA
Tamaru, Y., Sumino, H., & Matsugi, A. (2023). Usefulness of the Cognitive Composition Test as an Early Discriminator of Mild Cognitive Impairment. Journal of Clinical Medicine, 12(3), 1203. https://doi.org/10.3390/jcm12031203
Vancouver
Tamaru Y, Sumino H, Matsugi A. Usefulness of the Cognitive Composition Test as an Early Discriminator of Mild Cognitive Impairment. Journal of Clinical Medicine. 2023;12(3):1203. doi:10.3390/jcm12031203
BibTeX
@article{Tamaru2023,
author = {Tamaru, Yoshiki and Sumino, Hiroyuki and Matsugi, Akiyoshi},
title = {Usefulness of the Cognitive Composition Test as an Early Discriminator of Mild Cognitive Impairment},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {3},
pages = {1203},
doi = {10.3390/jcm12031203}
}
EUVIMED